Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Amines, anticonvulsants, and epilepsy.

D Chadwick, P Jenner, E H Reynolds

    Lancet (London, England)
    |March 1, 1975
    PubMed
    Summary
    This summary is machine-generated.

    Anticonvulsant drugs significantly increase levels of 5-hydroxyindoleacetic acid (5-HIAA) and homovanillic acid (HVA) in cerebrospinal fluid (CSF). These elevations correlate with drug dosage and potential toxicity in epilepsy patients.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    HIV testing in primary care in a low-prevalence area of Northeast England.

    HIV medicine·2025
    Same author

    British HIV Association guidelines on the management of opportunistic infection in people living with HIV: Considerations in pregnancy 2024.

    HIV medicine·2024
    Same author

    Anglo-French neurological interactions in the 19th and early 20th centuries: Societies and Journals.

    Revue neurologique·2022
    Same author

    Safe provision of elective endocrine surgery operations amid the COVID-19 crisis.

    Annals of the Royal College of Surgeons of England·2021
    Same author

    Author response: Post-thyroidectomy bleeding: analysis of risk factors from a national registry.

    The British journal of surgery·2021
    Same author

    Anglo-French neurological interactions in the 19th and early 20th centuries: Physicians, places and events.

    Revue neurologique·2021
    Same journal

    Assisted dying and the silencing of medicine's next generation.

    Lancet (London, England)·2026
    Same journal

    Linguistic pragmatism: a woman with progressive abdominal pain in Thailand.

    Lancet (London, England)·2026
    Same journal

    Medical compartmentalisation: a patient with chromosome 22q11.2 deletion syndrome in Japan.

    Lancet (London, England)·2026
    Same journal

    [<sup>177</sup>Lu]Lu-edotreotide versus everolimus for gastroenteropancreatic neuroendocrine tumours (COMPETE): a phase 3, multicentre, randomised, open-label, superiority trial.

    Lancet (London, England)·2026
    Same journal

    Research priorities for characterising Bundibugyo virus.

    Lancet (London, England)·2026
    Same journal

    Rethinking treatment sequence in advanced gastroenteropancreatic neuroendocrine tumours.

    Lancet (London, England)·2026
    See all related articles

    Area of Science:

    • Neurochemistry
    • Pharmacology
    • Neurology

    Background:

    • Epilepsy is a neurological disorder characterized by recurrent seizures.
    • Anticonvulsant drugs are the primary treatment for epilepsy.
    • The neurochemical effects of anticonvulsants, particularly on monoamine metabolites, require further investigation.

    Purpose of the Study:

    • To investigate the effect of anticonvulsant therapy on cerebrospinal fluid (CSF) levels of 5-hydroxyindoleacetic acid (5-HIAA) and homovanillic acid (HVA).
    • To explore the relationship between CSF monoamine metabolite levels, therapeutic drug levels, and clinical intoxication.
    • To understand the implications for the antiepileptic and toxic effects of anticonvulsant drugs.

    Main Methods:

    • Measurement of 5-HIAA and HVA concentrations in the CSF of three groups: anticonvulsant-treated epileptic patients, untreated epileptic patients, and neurological controls.

    Related Experiment Videos

  • Correlation analysis between CSF metabolite levels and blood concentrations of phenobarbitone and diphenylhydantoin.
  • Assessment of metabolite levels in relation to clinical signs of drug intoxication.

    • Main Results:

    • Significantly higher CSF 5-HIAA concentrations were observed in anticonvulsant-treated epileptic patients compared to untreated epileptics and controls.
    • Elevated CSF 5-HIAA levels were associated with achieving therapeutic blood levels of phenobarbitone and diphenylhydantoin, and were most pronounced in clinically intoxicated patients.
    • Similar trends were noted for CSF HVA, with a close correlation observed between CSF 5-HIAA and HVA, particularly in treated epileptic patients.

    Conclusions:

    • Anticonvulsant drug treatment leads to a significant increase in CSF 5-HIAA and HVA levels.
    • These changes are dose-dependent and may be indicative of drug toxicity.
    • The findings provide insights into the neurochemical mechanisms underlying the efficacy and side effects of anticonvulsant medications.